Clearmind Medicine Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Clearmind Medicine Inc.
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.
/ 
Frequently asked questions
To buy Clearmind Medicine Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Clearmind Medicine Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Clearmind Medicine Inc. is CMND:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Clearmind Medicine Inc. has its primary listing on NASDAQ (Small cap). You can trade Clearmind Medicine Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Clearmind Medicine Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Clearmind Medicine Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures - so you can make more informed decisions when considering shares like Clearmind Medicine Inc. or others.